Skip to main content
. 2016 Nov 21;13(1):169–179. doi: 10.1080/21645515.2016.1227900

Table 5.

Human leukocyte antigen (HLA) phenotype and postvaccination titer.

Treatment HLA-DRB1 Phenotype HLA-DQB1 Phenotype Day 28 Post vaccination Titer
Control 1 0401/1501 0302/0602 < 10
Control 2 0401/0701 0301/0319 / 0202 < 10
Control 3 0301/0701 0201/0202 < 10
Control 4 0701/1302 0202/0302 < 10
Control 5 0101/0701 0501/0303 < 10
Control 6 0301/1602 0201/0502 < 10
Control 7 0401/0701 0302/0202 < 10
Control 8 0101/0701 0501/0303 < 10
Control 9 0401/0701 0301/0319 / 0202 < 10
Control 10 0302/1503 0402/0602 < 10
Vaccinee 1 1101/1302 0301/0319 / 0604/0634 < 10*
Vaccinee 2 0402/0701 0302/0202 20
Vaccinee 3 0301/0401 0202 / 0301/0319 40
Vaccinee 4 0402/0701 0302/0202 80
Vaccinee 5 0801/1501 0402/0602 160
Vaccinee 6 1101/1302 0301/0319 / 0609 160
Vaccinee 7 0401/0701 0202/0302 320
Vaccinee 8 0701/1501 0202/0602 320
Vaccinee 9 0701/1401 0303/0503 1280
Vaccinee 10 1501 0602 1280

*Titer repeated at Day 56; Subject confirmed as vaccine NonResponder